GO
Loading...

Cramer: Buy Eli Lilly

Tuesday, 5 May 2009 | 3:00 PM ET

Eli Lilly is “the right pharma to own in this environment,” Cramer said during Tuesday’s Stop Trading.

Lilly is a fast-growing company with a great balance sheet and dividend, offering investors both defense and upside.

“It continues to astound me that you can by this stock this cheaply,” Cramer said. “Lilly is a buy.”

Stop Trading, Listen to Cramer!
Mad Money host Jim Cramer shares his stock picks with CNBC's Erin Burnett.

Elsewhere in the market, Cramer thinks that Boeing “may be the cheapest stock in the Dow Jones Averages.” He’s expecting 2010 to be a stronger year than this one for the company, as worker headcount has been cut, orders are on the rise and defense contractors on the whole have been doing well.

Lastly, Cramer urged investors to buy into real estate investment trust equity offerings. Whether retailers or health-care focused REITs, these stock deals have immediately gone to premium, producing quick returns.

“There’s some easy money being made in this group,” Cramer said.

Call Cramer: 1-800-743-CBNC

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the Mad Money website? madcap@cnbc.com

  Price   Change %Change
LLY
---
BA
---

Featured

Contact Mad Money

  • Showtimes

    Monday - Friday 6p ET
  • Jim Cramer is host of CNBC's "Mad Money" and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."

Mad Money Features

  • Grab the latest CNBC gear from the NBCUniversal Store!

  • Get a behind-the-scenes look at how Cramer formulates his investment advice. "Inside the Madness" is a column, which features e-mails and more with Cramer and his researcher Nicole Urken.

  • You’ve always wanted to hit the “Hallelujah!” button. Here’s your chance.